The role of the MTHFR gene in migraine

Headache

Volumn 52, Issue 3, 2012, Pages 515-520

  Stuart, Shani ^a   Cox, Hannah C ^a   Lea, Rod A ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

methylenetetrahydrofolate reductase gene; migraine with aura; Norfolk Island population

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM CHANNEL CACNA1A; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CYANOCOBALAMIN; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE; FOLIC ACID; HOMOCYSTEINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL SUBFAMILY K MEMBER 18; POTASSIUM CHANNEL SUBFAMILY K MEMBER 2; PYRIDOXINE; SODIUM POTASSIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE ALPHA2 POLYPEPTIDE; THYMINE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL TYPE I ALPHA SUBUNIT;

ARTICLE; BRAIN BLOOD FLOW; EXON; FRAMESHIFT MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; INDEL MUTATION; INTRON; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NORFOLK ISLAND; OCCIPITAL LOBE; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPREADING CORTICAL DEPRESSION; STROKE; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION;

AUSTRALIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMINS;

EID: 84858336642     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02106.x     Document Type: Article

References (60)

1. Lipton RB, Bigal ME,. The epidemiology of migraine. Am J Med. 2005; 118 (Suppl. 1): 3S-10S.
2. Olesen J,. Preface to the second edition. Cephalalgia. 2004; 24: 9-10. (Pubitemid 38091113)
3. Hadjikhani N, Sanchez Del Rio M, Wu O, et al,. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001; 98: 4687-4692. (Pubitemid 32295037)
4. Gervil M, Ulrich V, Kyvik KO, Olesen J, Russell MB,. Migraine without aura: A population-based twin study. Ann Neurol. 1999; 46: 606-611. (Pubitemid 29466439)
5. Mulder EJ, Van Baal C, Gaist D, et al,. Genetic and environmental influences on migraine: A twin study across six countries. Twin Res. 2003; 6: 422-431. (Pubitemid 38019780)
6. Stewart WF, Bigal ME, Kolodner K, Dowson A, Liberman JN, Lipton RB,. Familial risk of migraine: Variation by proband age at onset and headache severity. Neurology. 2006; 66: 344-348. (Pubitemid 43739934)
7. Ophoff RA, van Eijk R, Sandkuijl LA, et al,. Genetic heterogeneity of familial hemiplegic migraine. Genomics. 1994; 22: 21-26. (Pubitemid 24234083)
8. Ophoff RA, Terwindt GM, Vergouwe MN, et al,. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996; 87: 543-552. (Pubitemid 26374327)
9. Barrett CF, van den Maagdenberg AM, Frants RR, Ferrari MD,. Familial hemiplegic migraine. Adv Genet. 2008; 63: 57-83.
10. Colson NJ, Lea RA, Quinlan S, Griffiths LR,. The role of vascular and hormonal genes in migraine susceptibility. Mol Genet Metab. 2006; 88: 107-113.
11. Fernandez F, Colson NJ, Griffiths LR,. Pharmacogenetics of migraine: Genetic variants and their potential role in migraine therapy. Pharmacogenomics. 2007; 8: 609-622. (Pubitemid 46939586)
12. Maher BH, Griffiths LR,. Identification of molecular genetic factors that influence migraine. Mol Genet Genomics. 2011; 285: 433-446.
13. Colson N, Fernandez F, Griffiths L,. Genetics of menstrual migraine: The molecular evidence. Curr Pain Headache Rep. 2010; 14: 389-395.
14. de Almeida RF, Leao IA, Gomes JB, da Silva AA Jr, Teixeira AL,. Migraine with persistent visual aura: Response to furosemide. Clinics (Sao Paulo). 2009; 64: 375-376.
15. Olesen J, Friberg L, Olsen TS, et al,. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990; 28: 791-798.
16. Geraud G, Denuelle M, Fabre N, Payoux P, Chollet F,. Positron emission tomographic studies of migraine. Rev Neurol (Paris). 2005; 161: 666-670. (Pubitemid 40934001)
17. Etminan M, Takkouche B, Isorna FC, Samii A,. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005; 330: 63.
18. Lafreniere RG, Cader MZ, Poulin JF, et al,. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010; 16: 1157-1160.
19. Enyedi P, Czirjak G,. Molecular background of leak K+ currents: Two-pore domain potassium channels. Physiol Rev. 2010; 90: 559-605.
20. Ferrari U, Empl M, Kim KS, Sostak P, Forderreuther S, Straube A,. Calcineurin inhibitor-induced headache: Clinical characteristics and possible mechanisms. Headache. 2005; 45: 211-214. (Pubitemid 40393209)
21. Goyette P, Sumner JS, Milos R, et al,. Human methylenetetrahydrofolate reductase: Isolation of cDNA mapping and mutation identification. Nat Genet. 1994; 7: 551. (Pubitemid 24308346)
22. Heux S, Morin F, Lea RA, Ovcaric M, Tajouri L, Griffiths LR,. The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res. 2004; 27: 663-667. (Pubitemid 39534508)
23. Frosst P, Blom HJ, Milos R, et al,. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111-113.
24. Graham IM, O'Callaghan P,. Vitamins, homocysteine and cardiovascular risk. Cardiovasc Drugs Ther. 2002; 16: 383-389. (Pubitemid 36255738)
25. Taylor LM Jr, DeFrang RD, Harris EJ Jr, Porter JM,. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg. 1991; 13: 128-136.
26. Mizrahi EH, Noy S, Sela BA, Fleissig Y, Arad M, Adunsky A,. Further evidence of interrelation between homocysteine and hypertension in stroke patients: A cross-sectional study. Isr Med Assoc J. 2003; 5: 791-794. (Pubitemid 37441373)
27. Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M,. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia. 2001; 21: 137-139. (Pubitemid 32575477)
28. Parsons AA, Strijbos PJ,. The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr Opin Pharmacol. 2003; 3: 73-77. (Pubitemid 36131330)
29. Das UN,. Folic acid says NO to vascular diseases. Nutrition. 2003; 19: 686-692. (Pubitemid 36794301)
30. van der Put NM, Gabreels F, Stevens EM, et al,. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet. 1998; 62: 1044-1051. (Pubitemid 28199004)
31. Weisberg IS, Jacques PF, Selhub J, et al,. The 1298A->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): In vitro expression and association with homocysteine. Atherosclerosis. 2001; 156: 409-415. (Pubitemid 32522922)
32. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K,. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000; 96: 762-764.
33. Kara I, Sazci A, Ergul E, Kaya G, Kilic G,. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003; 111: 84-90. (Pubitemid 36332332)
34. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR,. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004; 2: 3.
35. Scher AI, Terwindt GM, Verschuren WM, et al,. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol. 2006; 59: 372-375. (Pubitemid 43202492)
36. Oterino A, Valle N, Bravo Y, et al,. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia. 2004; 24: 491-494. (Pubitemid 38748031)
37. Oterino A, Valle N, Pascual J, et al,. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele. Brain Res Mol Brain Res. 2005; 139: 163-168. (Pubitemid 41583598)
38. Todt U, Freudenberg J, Goebel I, et al,. MTHFR C677T polymorphism and migraine with aura. Ann Neurol. 2006; 60: 621-622; author reply 2-3. (Pubitemid 44871813)
39. Kaunisto MA, Kallela M, Hämäläinen E, et al,. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006; 26: 1462-1472.
40. Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L,. Association of the C677T polymorphism in the MTHFR gene with migraine: A meta-analysis. Cephalalgia. 2009; 29: 818-825.
41. Sharma P,. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry. 1998; 64: 227-230. (Pubitemid 28159806)
42. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F,. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86: 1343-1346. (Pubitemid 20370444)
43. Paterna S, Di Pasquale P, Cottone C, et al,. Migraine without aura and ACE-gene deletion polymorphism: Is there a correlation? Preliminary findings. Cardiovasc Drugs Ther. 1997; 11: 603-604. (Pubitemid 27440251)
44. Paterna S, Di Pasquale P, D'Angelo A, et al,. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 2000; 43: 133-136. (Pubitemid 30189532)
45. Kowa H, Fusayasu E, Ijiri T, et al,. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett. 2005; 374: 129-131. (Pubitemid 40092210)
46. Lea RA, Ovcaric M, Sundholm J, Solyom L, Macmillan J, Griffiths LR,. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res. 2005; 136: 112-117. (Pubitemid 40711189)
47. Lea R, Colson N, Quinlan S, Macmillan J, Griffiths L,. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet Genomics. 2009; 19: 422-428.
48. Wang X, Qin X, Demirtas H, et al,. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet. 2007; 369: 1876-1882. (Pubitemid 46829358)
49. Cox HLR, Bellis C, Carless M, Dyer T, Blangero J, Griffiths L,. Variants in the human potassium channel gene (KCNN3) are associated with migraine in a high risk genetic isolate. J Headache Pain. 2011; 6: 603-608.
50. McEvoy BP, Zhao ZZ, Macgregor S, et al,. European and Polynesian admixture in the Norfolk Island population. Heredity (Edinb). 2010; 105: 229-234.
51. Bellis C, Cox HC, Dyer TD, et al,. Linkage mapping of CVD risk traits in the isolated Norfolk Island population. Hum Genet. 2008; 124: 543-552.
52. Bellis C, Cox HC, Ovcaric M, et al,. Linkage disequilibrium analysis in the genetically isolated Norfolk Island population. Heredity (Edinb). 2008; 100: 366-373. (Pubitemid 351441856)
53. Boerwinkle E, Chakraborty R, Sing CF,. The use of measured genotype information in the analysis of quantitative phenotypes in man.1. Models and analytical methods. Ann Hum Genet. 1986; 50: 181-194. (Pubitemid 16116788)
54. Blangero J, Goring HH, Kent JW Jr, et al,. Quantitative trait nucleotide analysis using Bayesian model selection. Hum Biol. 2005; 77: 541-559. (Pubitemid 43375840)
55. Geer LY, Marchler-Bauer A, Geer RC, et al,. The NCBI BioSystems database. Nucleic Acids Res. 2010;38(Database issue):D492-6. (Epub 2009 Oct 23) [PubMed PMID: 19854944. Accessed 20/06/2011, at http://www.ncbi.nlm.nih.gov).
56. Liu P, Lu Y, Recker RR, Deng HW, Dvornyk V,. Association analyses suggest multiple interaction effects of the methylenetetrahydrofolate reductase polymorphisms on timing of menarche and natural menopause in white women. Menopause. 2010; 17: 185-190.
57. Levine AJ, Figueiredo JC, Lee W, et al,. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev. 2010; 19: 89-100.
58. Liu X, Zhao LJ, Liu YJ, Xiong DH, Recker RR, Deng HW,. The MTHFR gene polymorphism is associated with lean body mass but not fat body mass. Hum Genet. 2008; 123: 189-196.
59. Giusti B, Saracini C, Bolli P, et al,. Early-onset ischaemic stroke: Analysis of 58 polymorphisms in 17 genes involved in methionine metabolism. Thromb Haemost. 2010; 104: 231-242.
60. Bufalino A, Ribeiro Paranaiba LM, Nascimento de Aquino S, Martelli-Junior H, Oliveira Swerts MS, Coletta RD,. Maternal polymorphisms in folic acid metabolic genes are associated with nonsyndromic cleft lip and/or palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol. 2010; 88: 980-986.